New Data is Presented on Investigational Oral Anticoagulant Apixaban in Acute Coronary Syndrome Patients (Centre Daily Times)

Bristol-Myers Squibb Company (NYSE: BMY) and Pfizer Inc (NYSE: PFE) announced today the results of a Phase 2 dose-ranging study (APPRAISE-1) involving the investigational compound apixaban in patients with acute coronary syndrome (ACS, commonly known as heart attack or severe chest pain). The study compared the current standard of care for ACS, including aspirin and clopidogrel, with apixaban on ...

Read full post here. Copyright (c) 2004 Yahoo! Inc. All rights reserved.

Related keywords: note taking skills,  drawing, concept map

More articles:
Exercise may help improve memory problems
Hoddinott Fine Art Publishers
SBC Academic Resource Center | Note-Taking Skills